序号 | 专利名 | 申请号 | 申请日 | 公开(公告)号 | 公开(公告)日 | 发明人 |
---|---|---|---|---|---|---|
181 | SIALYLTRANSFERASE INHIBITORS AND USES THEREOF | EP16840229.5 | 2016-08-26 | EP3341387A1 | 2018-07-04 | LI, Wen-Shan; HUNG, Wen-Chun; SHEN, Chia-Ning |
Disclosed herein are novel sialyltransferase inhibitors, and compositions and methods for treating diseases and/or conditions associated with the activation of sialyltransferase, such as a cancer, an immune disease or an inflammatory disease. | ||||||
182 | 16-Hydroxyestratriene als selektiv wirksame Estrogene | EP05075149.4 | 2000-02-09 | EP1580192A2 | 2005-09-28 | Künzer, Hermann, Dr.; Knauthe, Rudolf, Dr.; Lessl, Monika, Dr.; Fritzemeier, Karl-Heinrich, Dr.; Hegele-Hartung, Christa, Dr.; Bömer, Ulf, Dr.; Müller, Gerd, Dr.; Kosemund, Dirk, Dr. |
Die Erfindung beschreibt neue Verbindungen als pharmazeutische Wirkstoffe, die in vitro eine höhere Affinität an Estrogenrezeptorpräparationen von Rattenprostata als an Estrogenrezeptorpräparationen von Rattenuterus und in vivo eine präferentielle Wirkung am Knochen im Vergleich zum Uterus und/oder ausgeprägte Wirkung hinsichtlich Stimulierung der Expression von 5HT2a-Rezeptor und -transporter aufweisen, deren Herstellung, ihre therapeutische Anwendung und pharmazeutischen Darreichungsformen, die die neuen Verbindungen enthalten. Bei den neuen Verbindungen handelt es sich um 16α- und 16β-Hydroxy-estra,1,3,5(10)-estratriene, die am Steroid-Gerüst weitere Substituenten tragen sowie in den B-, C-und/oder D-Ringen eine oder mehrere zusätzliche Doppelbindungen aufweisen können. |
||||||
183 | Pharmaceutical compositions having appetite suppressant activity | EP02004101.8 | 1998-04-15 | EP1213020A3 | 2005-03-09 | Van Heerden, Fanie Retief; Vleggaar, Robert; Horak, Roelof Marthinus; Learmonth, Robin Alec; Maharaj, Vinesh; Whittal, Rory Desmond |
The present invention relates to a surface cutting apparatus for hot-rolled steel products for cutting the top and bottom surfaces of a hot-rolled steel product continuously or intermittently by passing said steel product between a pair of rotary drums (38a,38b) rotating in the direction reverse to each other, said apparatus having a disk (39a,39b) for recognizing a gap between the rotary drums (38a,38b), which has a diameter larger than that of said rotary drum, at both ends or one end of at least one rotary drum (38a,38b). |
||||||
184 | Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite | EP04002070.3 | 1998-04-15 | EP1438965A1 | 2004-07-21 | van Heerden, Fanie Retief; Vleggaar, Robert; Horak, Roelof Marthinus; Learmonth, Robin Alec; Maharaj, Vinesh; Whittal, Rory Desmond |
Extracts obtainable from Hoodia gordonii or lugardii containing an appetite suppressant agent having the formula (1) are disclosed for the manufacture of medicaments having appetite suppressant activity. |
||||||
185 | Pharmaceutical compositions having appetite suppressant activity | EP02004101.8 | 1998-04-15 | EP1213020A8 | 2003-12-17 | Van Heerden, Fanie Retief; Vleggaar, Robert; Horak, Roelof Marthinus; Learmonth, Robin Alec; Maharaj, Vinesh; Whittal, Rory Desmond |
A pharmaceutical composition contains an extract obtainable from a plant of the genus Trichocaulon or Hoodia containing an appetite suppressant agent having the formula (1). A process for obtaining the extract and a process for synthesizing compound (1) and it analogues and derivatives is also provided. The invention also extends to the use of such extracts and compound (1) and its analogues for the manufacture of medicaments having appetite suppressant activity. The invention further provides novel intermediates for the synthesis of compound (1). |
||||||
186 | 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS | EP00929510.6 | 2000-05-05 | EP1177205A1 | 2002-02-06 | ESPERLING, Peter; KUHNKE, Joachim; LAURENT, Henry; BLUME, Thorsten; HEGELE-HARTUNG, Christa; LESSL, Monika |
The present invention relates to pharmaceutically active 14β-H-sterols, to pharmaceutical compositions comprising them and to the use of these novel compounds for the preparation of medicaments. More particularly it has been found that the 14β-H-sterols of the invention can be used for regulating meiosis. | ||||||
187 | Improved process for the preparation of 3 beta, 14 beta-dihydroxyethialnaldehyde | EP95830069.1 | 1995-03-03 | EP0684256B1 | 1998-05-13 | Gobbini, Mauro; Torri, Marco |
188 | 13-Alkyl-11Beta-phenylgonane | EP89730155.2 | 1989-07-03 | EP0349481B1 | 1995-11-02 | Scholz, Stefan, Dr.; Ottow, Eckhard, Dr.; Neef, Günter, Dr.; Elger, Walter, Dr.; Beier, Sybille, Dr.; Chwalisz, Krzysztof, Dr. |
189 | EP0669931A4 - | EP94902304 | 1993-11-18 | EP0669931A4 | 1995-10-04 | |
190 | Method of preparating 9beta, 10alpha-5,7-diene steroids | EP93200423.7 | 1993-02-16 | EP0558119A2 | 1993-09-01 | Bout, Berthus; Voorhaar, Ronald |
The invention relates to a method of preparing a 9beta,10alpha-5,7-diene steroid by irradiating the corresponding 9alpha,10beta-5,7-diene steroid with filtered ultraviolet light from an indium lamp. |
||||||
191 | New ll-aryl steroid derivatives | EP88200071.4 | 1988-01-18 | EP0277676B1 | 1992-03-04 | Loozen, Hubert Jan Jozef |
192 | 11Beta-phenyl-14betaH-steroide | EP89250040.6 | 1989-09-20 | EP0360369A1 | 1990-03-28 | Scholz, Stefan, Dr.; Neef, Günter, Dr.; Ottow, Eckhard, Dr.; Elger, Walter, Dr.; Beier, Sybille, Dr.; Chwalisz, Krzysztof, Dr. |
Neue 11β-Phenyl-14ßH-steroide der allgemeinen Formel l
|
||||||
193 | 13-Alkyl-11Beta-phenylgonane | EP89730155.2 | 1989-07-03 | EP0349481A1 | 1990-01-03 | Scholz, Stefan, Dr.; Ottow, Eckhard, Dr.; Neef, Günter, Dr.; Elger, Walter, Dr.; Beier, Sybille, Dr.; Chwalisz, Krzysztof, Dr. |
Es werden 13-Alkyl-11ß-phenyl-gonane der allgemeinen Formel I
Die neuen Verbindungen der allgemeinen Formel I besitzen hervorragende antigestagene Wirksamkeit. |
||||||
194 | Method of preparing 9beta,10alpha-5,7-diene-steroids | EP85200115.5 | 1985-02-04 | EP0152138B1 | 1988-01-13 | Rappoldt, Menso P.; Mos, Gerardus H.M. |
195 | 11-Beta phenyl gonanes, their preparation and pharmaceutical compositions containing them | EP86101548 | 1986-02-06 | EP0190759A3 | 1986-11-20 | Neef, Günter, Dr.; Wiechert, Rudolf, Prof.; Ottow, Eckard, Dr.; Rohde, Ralph. Dr.; Beier, Sybille, Dr.; Elger, Walter, Dr.; Henderson, David, Dr. |
196 | 11 Beta-Phenyl-Gonane, deren Herstellung und diese enthaltende pharmazeutische Präparate | EP86101548.5 | 1986-02-06 | EP0190759A2 | 1986-08-13 | Neef, Günter, Dr.; Wiechert, Rudolf, Prof.; Ottow, Eckard, Dr.; Rohde, Ralph. Dr.; Beier, Sybille, Dr.; Elger, Walter, Dr.; Henderson, David, Dr. |
Es warden neve 13-Alkyl-11ß-phenyl-gonane der allgemeinen Formel
Die neuen 11ß-Phenyl-Gonane besitzen antigestagene und antiglucocorticoide Wirkungen. |
||||||
197 | New 8-alpha-oestra-1,3,5(10)-triene derivatives, processes for their preparation and pharmaceutical compositions | EP81200741.7 | 1981-07-01 | EP0044105A2 | 1982-01-20 | Groen, Marinus Bernard, Dr. |
The invention relates to new 8a-oestra-1,3,5(10)-triene derivatives having the formula:
|
||||||
198 | STEROIDS AND METHODS OF MANUFACTURE | US17818873 | 2022-08-10 | US20230018615A1 | 2023-01-19 | Glenn C. Micalizio |
Methods for producing enantiodefined polycyclic compounds, particularly tetracyclic compounds, are provided. More particularly, synthetic methods for producing biologically active enantiodefined steroidal compositions of both natural (“nat-”) and unnatural (“ent-”) absolute stereochemistry are provided. An exemplary method for manufacturing a tetracyclic compound comprises a step of forming a hydrindane intermediate through coupling of a suitably functionalized enyne with a suitably functionalized alkyne and subsequently performing an intramolecular ring-closing reaction to form the tetracyclic compound. Steroidal compounds obtained by this method and methods of using such steroidal compounds in human and/or animal therapeutics and medicines are also provided. | ||||||
199 | Steroids and methods of manufacture | US16637675 | 2018-08-16 | US11459353B2 | 2022-10-04 | Glenn C. Micalizio |
Methods for producing enantiodefined polycyclic compounds, particularly tetracyclic compounds, are provided. More particularly, synthetic methods for producing biologically active enantiodefined steroidal compositions of both natural (“nat-”) and unnatural (“ent-”) absolute stereochemistry are provided. An exemplary method for manufacturing a tetracyclic compound comprises a step of forming a hydrindane intermediate through coupling of a suitably functionalized enyne with a suitably functionalized alkyne and subsequently performing an intramolecular ring-closing reaction to form the tetracyclic compound. Steroidal compounds obtained by this method and methods of using such steroidal compounds in human and/or animal therapeutics and medicines are also provided. | ||||||
200 | 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | US17560732 | 2021-12-23 | US20220110950A1 | 2022-04-14 | Gabriel Martinez Botella; Boyd L. Harrison; Albert Jean Robichaud; Francesco G. Salituro; Richard Thomas Beresis |
Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I): and pharmaceutically acceptable salts thereof; wherein , R1, R2, R3a, R3b, R4a, R4b, R5, R6, and R7 are as defined herein. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, convulsive disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, and tinnitus. |